EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT: SHAREHOLDER BILL OF RIGHTS

1/8/2024

If you suffered losses in Eagle Pharmaceuticals stock, contact Eagle Pharmaceuticals stock loss lawyer Timothy L. Miles

introduction to the EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT

Contact Eagle Pharmaceuticals stock loss lawyer Timothy L. Miles about an Eagle Pharmaceuticals class action lawsuit

The Eagle Pharmaceuticals class action lawsuit seeks to represent purchasers or acquirers of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) securities between August 8, 2023 and November 28, 2023, inclusive (the “Class Period”). Captioned Miller v. Eagle Pharmaceuticals, Inc., No. 23-cv-23011 (D.N.J.), the Eagle Pharmaceuticals class action lawsuit charges Eagle Pharmaceuticals and certain of its top current and former executive officers with violations of the Securities Exchange Act of 1934.

If you suffered losses in Eagle Pharmaceuticals stock and wish to serve as lead plaintiff in the Eagle Pharmaceuticals class action lawsuit, or just have general questions about your rights as a shareholder, please contact Eagle Pharmaceuticals Stock Loss Lawyer Timothy L. Miles at no charge by calling 855/846-6529 or via e-mail at [email protected] or by submitting a contact form. Lead plaintiff motions for the Eagle Pharmaceuticals class action lawsuit must be filed with the court no later than February 9, 2024.

Read on to learn the rights you possess as a shareholder in the Eagle Pharmaceuticals class action lawsuit.

YOU HAVE THE RIGHT TO MOVE FOR LEAD PLAINTIFF IN THE EAGLE PHARMACEUTICALSCLASS ACTION LAWSUIT

Any investor who purchased and suffered losses in Eagle Pharmaceuticals stock has the right to seek an appointment as lead plaintiff in the Eagle Pharmaceuticals class action lawsuit. The lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. If you believe you meet these criteria, you have the right to move the court to be appointed lead plaintiff. If you decide you want to move for lead plaintiff status, remember Lead plaintiff motions for the Eagle Pharmaceuticals class action lawsuit must be filed with the court no later than February 9, 2024.

YOU HAVE THE RIGHT TO OPT-OUT OF THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT

When it comes to participating in the Eagle Pharmaceuticals lawsuit, you have two options. First, you can do nothing and remain a member of the class represented by lead counsel. Second, if you believe you have a large enough loss to justify it, you have the right to opt out of the Eagle Pharmaceuticals lawsuit and file your own separate lawsuit. Note, that if you opt-out, you will not be able to participate in any settlement or recovery obtained in the Eagle Pharmaceuticals lawsuit.

YOU HAVE THE RIGHT TO PARTICIPATE IN THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT EVEN IF YOU RECEIVED COMPENSATION FROM FINRA

The acceptance of restitution or compensation from a FINRA regulatory settlement does not waive your right to monetary or other benefits through the courts, arbitration, or mediation. Therefore, even if you received a settlement from FINRA, you could still participate in the There is no requirement for you to retain ownership of the stock after the class period has expired to participate in the Eagle Pharmaceuticals class action lawsuit.

YOU HAVE THE RIGHT TO SELL YOU STOCK AND STILL BE A MEMBER OF THE CLASS IN THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT

There is no requirement for you to retain ownership of the stock after the class period has expired to participate in the Eagle Pharmaceuticals class action lawsuit.

YOU HAVE THE RIGHT TO OBJECT TO ANY SETTLEMENT YOU DO NOT BELIEVE IS FAIR

If you receive a notice that the Eagle Pharmaceuticals lawsuit has been settled and you do not believe the settlement is fair but do not want to opt and file your own lawsuit, you have the right to object to the settlement. You may object to any part of the settlement and the Court will consider all timely filed objections in the Eagle Pharmaceuticals lawsuit. The notice will contain the date when any objections must be filed and will include instructions on where to send your objection and will also include a date for the final hearing in the Eagle Pharmaceuticals lawsuit if you would like to appear and be heard by the court in the class action against Eagle Pharmaceuticals.

IF YOU ARE A NON-U.S. INVESTOR YOU HAVE THE RIGHT TO MOVE TO BE LEAD PLAINTIFF IN THE EAGLE PHARMACEUTICALS LAWSUIT

Courts in the U.S. have consistently recognized that non-U.S. investors, many of whom have substantial holdings, are adequate lead plaintiffs and have the same right to move for lead plaintiffs as U.S. investors. Thus, if a non-U.S. investor suffered losses in Eagle Pharmaceuticals, they may move the Court to be appointed lead plaintiff in the Eagle Pharmaceuticals lawsuit.

YOU HAVE THE RIGHT TO BE A LEAD PLAINTIFF IN THE EAGLE PHARMACEUTICALS LAWSUIT EVEN IF YOU ARE A LEAD PLAINTIFF IN ANOTHER SECURITIES CLASS ACTOIN

Unless you have been a lead plaintiff in more than five securities class actions during any three-year period which is expressly prohibited by the securities laws. Otherwise, if you suffered losses in Eagle Pharmaceuticals stock, you may move to be appointed lead plaintiff in the Eagle Pharmaceuticals class action lawsuit.

YOU HAVE THE RIGHT TO RETAIN AN ATTORNEY AT NO CHARGE

If you suffered losses in Eagle Pharmaceuticals and are a member of the class, it does not cost anything to hire an Eagle Pharmaceuticals stock loss lawyer. Our firm litigates securities fraud cases on a contingent fee basis, so plaintiffs and the class do not pay attorneys’ fees or court costs unless there is a recovery, and the attorney fees and costs are awarded by the court as a percentage of the total recovery for the class. So, contact an Eagle Pharmaceuticals stock loss lawyer today if you suffered losses in Eagle Pharmaceuticals stock about an Eagle Pharmaceuticals class action lawsuit.

YOU HAVE THE RIGHT TO CONTACT ME FOR NO CHARGE AT ANYTIME IF YOU HAVE ANY QUESTIONS ABOUT YOUR RIGHTS AS A SHAREHOLDER

If you have any questions about these or any other rights you have as a shareholder do not hesitate to contact me anytime for no-charge. (855) TIM-M-LAW (855/846-6529).

CONTACT AN EAGLE PHARMACEUTICALS STOCK LOSS LAWYER TODAY IF YOU SUFFERED LOSSES IN EAGLE PHARMACEUTICALS STOCK ABOUT A EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT

If you suffered losses in Eagle Pharmaceuticals stock, contact Eagle Pharmaceuticals stock loss lawyer Timothy L. Miles today for a free case evaluation about an Eagle Pharmaceuticals class action lawsuit. Call today and see what an Eagle Pharmaceuticals stock loss lawyer could do for you if you suffered losses in Eagle Pharmaceuticals stock.

Eagle Pharmaceuticals stock loss lawyer Timothy L. Miles

Nashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,Class Action: Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM (2019-2022); Americas Most Honored Lawyers 2020 â€“ Top 1% by America's Most Honored (2020-2022). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more. Please visit our website or call for free anytime.

CONTACT
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr., #247
Brentwood, TN 37027
Phone: (855) 846-6529